TELEFLEX INC financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data TELEFLEX INC files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	1,868	2,146	2,448	2,595	2,537	2,810	2,791	1,712	1,700	1,993
Cost of revenue	872	975	1,146	1,186	1,212	1,260	1,260	672	662	872
Gross profit	996	1,172	1,303	1,409	1,325	1,550	1,531	1,040	1,037	1,121
Research and development	58.6	84.8	106	114	120	131	154	114	109	145
Selling, general and administrative	563	700	797	852	744	860	864	623	675	720
Operating income	319	372	322	427	423	628	500	259	104	118
Interest expense	54.9	82.5	103	80.3	66.5	57	54.3	85.1	83.5	100
Interest income	0.47	0.77	0.94	1.74	1.16	1.33	0.91	11.7	6.15	6.4
Pre-tax income	246	285	220	340	358	559	446	185	26.3	24.6
Income tax	8.07	130	23.2	-122	21.9	74.3	83	41.9	-30.9	-34
Income from continuing operations	237	155	196
Net income	237	153	201	461	335	485	363	356	69.7	-906
EBITDA	448	533	536	646	650	865	730	407	265	296
EPS, basic	5.48	3.39	4.39	9.99	7.21	10.38	7.74	7.58	1.49	-20.30
EPS, diluted	4.98	3.27	4.29	9.80	7.09	10.23	7.68	7.53	1.48	-20.25
Shares, basic (weighted)	43.3	45	45.7	46.2	46.5	46.8	46.9	47	46.8	44.6
Shares, diluted (weighted)	47.6	46.7	46.8	47.1	47.3	47.4	47.3	47.3	47.1	44.7
Dividend per share	1.36	1.36	1.36	1.36	1.36	1.36	1.36	1.36	1.36	1.36

Balance sheet

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash and equivalents	544	334	357	301	376	445	292	223	248	379
Receivables	272	346	366	419	395	384	409	443	227	346
Inventory	316	396	428	477	513	478	579	626	307	404
Other current assets	40.4	47.9	72.5	97.9	115	117	125	107	102	151
Total current assets	1,183	1,129	1,236	1,306	1,422	1,429	1,411	1,407	1,471	1,938
Property, plant and equipment	303	383	433	431	474	444	447	480	308	498
Lease right-of-use assets				113	101	130	131	124	95.7	91.8
Goodwill	1,277	2,236	2,247	2,245	2,586	2,504	2,537	2,914	1,992	2,305
Intangible assets	1,092	2,384	2,325	2,156	2,520	2,289	2,306	2,502	1,348	1,524
Other non-current assets	34.8	46.5	35	52.4	41.8	69.1	89.4	98.9	101	113
Total assets	3,891	6,181	6,278	6,310	7,153	6,872	6,928	7,533	7,098	6,947
Accounts payable	69.4	92	107	103	103	118	127	132	97.9	130
Accrued liabilities	65.1	96.9	97.6	100	136	163	141	147	108	117
Short-term debt	183	86.6	86.6	50	101	110	87.5	87.5	100	100
Total current liabilities	428	484	582	563	540	680	581	607	649	762
Long-term debt	850	2,163	2,072	1,859	2,378	1,740	1,624	1,728	1,556	2,541
Lease liabilities				101	86.1	116	120	111	88	195
Other non-current liabilities	45.5	169	204	203	243	157	154	163	118	53
Total liabilities	1,752	3,751	3,738	3,331	3,816	3,117	2,906	3,092	2,820	3,822
Total debt	1,033	2,250	2,159	1,909	2,478	1,850	1,712	1,815	1,656	2,641
Paid-in capital	507	592	575	617	652	693	715	750	781	816
Retained earnings	2,195	2,286	2,428	2,825	3,096	3,518	3,817	4,110	4,116	3,150
Treasury stock	-171	-229	-169	-166	-163	-157	-155	-152	-350	-650
Other comprehensive income	-439	-265	-341	-344	-297	-347	-404	-314	-317	-239
Shareholders' equity	2,138	2,431	2,540	2,979	3,336	3,755	4,022	4,441	4,278	3,125
Minority interests	0
Total equity	2,138	2,431	2,540	2,979	3,336	3,755	4,022	4,441	4,278	3,125
Total liabilities and equity	3,891	6,181	6,278	6,310	7,153	6,872	6,928	7,533	7,098	6,947

Cash flow statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Net income	238	153	201	461	335	485	363	356	69.7	-906
Depreciation and amortization	128	160	215	218	227	237	231	148	162	178
Stock-based compensation	16.9	19.4	22.4	26.9	20.7	22.9	27.2	27.3	26	25.7
Deferred income tax	-29.3	-41.8	-6.1	-169	-32.7	-110	-13	-7.92	-113	-101
Change in receivables	-11	-11	-23.4	-59.8	44.7	-0.6	-38.5	-4.38	-3.6	-85.5
Change in inventory	6.41	-22.4	-37.2	-53.2	-5.5	-11.1	-111	-56.4	6.75	84
Change in payables	15.4	39	62.4	36	0.65	94	-24.8	-18.9	2.35	-8.28
Cash from operations	411	426	435	437	437	652	343	206	302	96.7
Capital expenditures	-53.1	-70.9	-80.8	-103	-90.7	-71.6	-79.2	-46.4	-90.4	-95.2
Purchases of investments				0	0	-18.4	-22.3	-11.3	-7.3	-5
Sales and maturities of investments				0	0	7.3	7.3	7.3	7.3	0
Cash from investing	-57	-1,833	-196	-73.5	-838	157	-259	27.3	-63.4	-813
Debt issued	672	2,464	35	275	1,514	400	744	646	130	1,140
Debt repaid	-715	-1,240	-129	-529	-939	-1,035	-885	-545	-292	-153
Stock issued	0	0	0	0
Share buybacks							0	0	-200	-300
Dividends paid	-59	-61.2	-62.2	-62.8	-63.2	-63.6	-63.8	-63.9	-63.5	-60.3
Cash from financing	-119	1,141	-206	-419	455	-716	-218	38.5	-422	612
Exchange rate effect	-27.4	61.5	-10.9	-3.29	21	-23.1	-19.7	2.86	-9.65	23.2
Net change in cash	205	-210	23.6	-56.1	74.8	69.2	-153	-69.2	105	126
Free cash flow	357	355	354	334	346	581	264	160	211	1.45
Interest paid	44.2	74.3	102	96	79.5	73.6	70.9	100	98.4	119
Income taxes paid	24	49.1	65.6	73.6	77.2	109	162	78.3	110	118

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $122.07 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	54.9%	Gross profit / revenue.
Operating margin	2.0%	Operating income / revenue.
EBITDA margin	8.5%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	-7.9%	Pre-tax income / revenue.
Net margin	-45.8%	Net income / revenue.
FCF margin	7.5%	Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin	10.8%	Cash from operations / revenue.
Return on equity (ROE)	-35.5%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	-15.2%	Net income / average total assets.
Return on invested capital (ROIC)	0.6%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
R&D / revenue	7.1%	Research and development expense / revenue.
SG&A / revenue	32.0%	Selling, general and administrative expense / revenue.
Stock-based pay / revenue	1.1%	Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue	3.4%	Capital expenditures / revenue.
D&A / revenue	6.6%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	17.2%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	-10.6%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	-4.7%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	8.0%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	-9.9%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y	-3.3%	Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y	14.2%	Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y	-38.1%	Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income CAGR, 5y	-22.5%	Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y	11.7%	EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y	-26.0%	Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y	-14.6%	Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y	-1,400.0%	Net income vs the same period a year earlier. Only from a positive base.
EPS growth, 1y	-1,468.0%	EPS vs the same period a year earlier. Only from a positive base.
Operating cash flow growth, 1y	-68.0%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y	-34.4%	Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y	-26.0%	Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y	-99.3%	Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 3y	-82.4%	Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow CAGR, 5y	-66.6%	Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Dividend per share growth, 1y	0.0%	Dividend per share vs the same period a year earlier. Only from a positive base.
Dividend per share CAGR, 3y	0.0%	Compound annual growth of dividend per share over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Dividend per share CAGR, 5y	0.0%	Compound annual growth of dividend per share over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y	-27.0%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	-8.1%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	-1.3%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	-2.1%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	0.1%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	-0.6%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	-5.0%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	-1.9%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	-1.1%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	2.60x	Current assets / current liabilities.
Quick ratio	0.92x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	0.42x	(Cash + short-term investments) / current liabilities.
Debt / equity	0.97x	Total debt / shareholders' equity. Not shown when equity is negative.
Debt / assets	41.4%	Total debt / total assets.
Liabilities / assets	57.2%	Total liabilities / total assets.
Net debt	$2.51B	Total debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA	13.0x	Net debt / EBITDA (twelve months), when EBITDA is positive.
Interest coverage	0.39x	Operating income / interest expense.
Working capital	$1.16B	Current assets - current liabilities.
Goodwill and intangibles / assets	55.1%	(Goodwill + intangible assets) / total assets.
Tangible book value	-$836.6M	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	0.33x	Revenue / average total assets.
Fixed asset turnover	4.74x	Revenue / average property, plant and equipment.
Inventory turnover	1.96x	Cost of revenue / average inventory.
Days inventory	186 days	365 x average inventory / cost of revenue.
Receivables turnover	6.18x	Revenue / average receivables.
Days sales outstanding	59 days	365 x average receivables / revenue.
Days payables	76 days	365 x average accounts payable / cost of revenue.
Cash conversion cycle	169 days	Days inventory + days sales outstanding - days payables.
Capex / operating cash flow	31.1%	Capital expenditures / cash from operations, when that is positive.

Per share

Metric	Value	How it is calculated
EPS, diluted	-$23.29	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$51.64	Revenue / diluted weighted shares.
FCF per share	$3.86	Free cash flow / diluted weighted shares.
Operating cash flow per share	$5.60	Cash from operations / diluted weighted shares.
Book value per share	$66.53	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	-$19.16	Tangible book value / shares outstanding.
Cash per share	$6.87	(Cash + short-term investments) / shares outstanding.
Dividends / FCF	35.6%	Dividends paid / free cash flow, when free cash flow is positive.
Buybacks / FCF	148.5%	Share buybacks / free cash flow, when free cash flow is positive.

Valuation

Metric	Value	How it is calculated
Market cap	$5.17B	Share price x shares outstanding.
Enterprise value	$7.68B	Market cap + total debt - cash - short-term investments.
P/S	2.29x	Market cap / revenue.
P/B	1.78x	Market cap / shareholders' equity. Only when equity is positive.
P/FCF	30.7x	Market cap / free cash flow. Only when free cash flow is positive.
P/OCF	21.2x	Market cap / cash from operations, when positive.
EV/Sales	3.41x	Enterprise value / revenue.
EV/EBIT	173x	Enterprise value / operating income, when both are positive.
EV/EBITDA	39.9x	Enterprise value / EBITDA, when both are positive.
EV/FCF	45.6x	Enterprise value / free cash flow, when both are positive.
FCF yield	3.3%	Free cash flow / market cap.
Earnings yield	-19.9%	Net income / market cap (the inverse of P/E).
Dividend yield	1.2%	Dividends paid over the period / market cap.
Shareholder yield	6.0%	(Dividends paid + share buybacks) / market cap.

What was TELEFLEX INC's revenue in fiscal 2025?

TELEFLEX INC reported revenue of $1.99B for fiscal 2025, 17.2% higher than the year before.

Was TELEFLEX INC profitable in fiscal 2025?

No. It reported a net loss of $905.6M.

How much free cash flow did TELEFLEX INC generate in fiscal 2025?

Cash from operations of $96.7M minus capital expenditures of $95.2M left free cash flow of $1.4M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to TELEFLEX INC